Posted on 8/7/20
InnovHeart Closes Series B Financing of €20 Million
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 . . .
Posted on 8/7/20
Jounce Therapeutics Reports Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 8/7/20
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
WOBURN, Mass., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today . . .
Posted on 8/7/20
Why Moderna Stock Rose 15.4% in July
What happenedShares of Moderna (NASDAQ:MRNA) climbed 15.4% in July, according to data provided by S&P Global Market Intelligence, as the company advanced its coronavirus vaccine program.Several . . .
Posted on 8/6/20
Interview with Guy D’Andrea, Founder and Managing Partner of Discern Health
As all aspects of healthcare continue to evolve amidst the COVID-19 pandemic, there remains an opportunity for companies to provide an integrated approach across the health . . .
Posted on 8/6/20
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and . . .
Posted on 8/6/20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results for the second quarter ended . . .
Posted on 8/6/20
AVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported financial . . .
Posted on 8/6/20
Concert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2020.“We continue to be committed to advancing both of our . . .
Posted on 8/6/20
Dicerna Announces Second Quarter 2020 Financial Results and Provides a Business Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today reported its financial results for the second quarter . . .
Posted on 8/6/20
Ironwood Pharmaceuticals Reports Second Quarter 2020 Results
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its second quarter 2020 results and recent business performance, as well . . .
Posted on 8/6/20
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
Norwood, MA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 8/6/20
Kymera Therapeutics Begins U.S. IPO Effort
Kymera Therapeutics (KYTX) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.The firm is a preclinical . . .
Posted on 8/6/20
CVS Health Crushes Q2 Earnings Estimates Thanks to COVID-19
CVS Health (NYSE:CVS) benefited from the COVID-19 pandemic in several ways during the first quarter. However, there were questions about whether the coronavirus outbreak would provide . . .
Posted on 8/6/20
How Moderna Went From Coronavirus Sequence to a Phase-1-Ready Vaccine Candidate in 42 Days
Moderna (NASDAQ:MRNA), one of the leaders in the race to develop a coronavirus vaccine, was able to take the initial coronavirus sequence and get a vaccine . . .
Posted on 8/5/20
Charles River Laboratories Announces Second-Quarter 2020 Results
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2020. For the quarter, revenue was $682.6 million, . . .
Posted on 8/5/20
Bicycle Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycles®) . . .
Posted on 8/5/20
Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, . . .
Posted on 8/5/20
Karuna Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with . . .
Posted on 8/5/20
Harvard Bioscience Announces Second Quarter 2020 Financial Results
HOLLISTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced financial results for the three and six months ended June 30, . . .
Posted on 8/5/20
Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update
CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop . . .
Posted on 8/5/20
EyePoint Pharmaceuticals Reports Q2 2020 Financial Results
WATERTOWN, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 8/5/20
Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?
We now have a pretty good idea how much COVID-19 vaccines will cost Uncle Sam. Last week, The U.S. government announced a deal with Pfizer (NYSE:PFE) . . .
Posted on 8/5/20
Thermo Fisher Increases Its Buyout Price for Qiagen, but Investors Ask for More
In one of the biggest deals of 2020, medical equipment giant Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Qiagen (NYSE:QGEN) in March for $11.5 billion. . . .
Posted on 8/4/20
Genuity Science Announces Strategic Collaboration with Nashville Biosciences
Genuity Science, a U.S.-headquartered contract genomics and data-sourcing, -analytics and -insights organization, today announces an agreement with Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical . . .
Boston
